bso glutathione inhibitor Effects of synthesis inhibition on EBV-infected, ≥99.0% (TLC) 250 mg Augment of Ferroptosis with Photothermal

Standard AOD-9604 Dosing Protocol Typical Dosing Range: Standard Dose: 250-500 mcg per day Clinical Trial Dose: 1 mg (1,000 mcg) per day (most effective in studies) Conservative Start: 250 mcg per day for first week Maintenance Range: 500 mcg per day for sustained protocols Frequency: Once daily, typically before breakfast Timing Rationale: Morning fasted state maximizes fat oxidation potential Cycle Length: 12-24 weeks for body composition protocols Administration Route: Subcutaneous injection (abdomen, thigh, or upper arm) Reconstitution: Bacteriostatic water, standard peptide protocols Note: Clinical trials used oral formulations, but subcutaneous administration is more common in current use due to improved bioavailability

Using this invasive technique, intra-arterial infusion of lipoic acid was found to improve endothelium-dependent vasodilation in 39 subjects with type 2 diabetes but not in 11 healthy controls (62)

The dual receptor activity offers a synergistic approach, potentially resulting in more significant weight loss and improved metabolic outcomes compared to therapies targeting a single receptor pathway

doi: 10.3389/fimmu.2024.1333429 181